A Clinical Study To Evaluate The Efficacy Of Zimad (Arad karasna with Shahad) In The Management Of Basoor-e-Labaniya (Acne Vulgaris)
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 44
- 试验地点
- 1
- 主要终点
- 1.Severity of acne
研究概览
简要总结
Acne vulgaris is one of the oldest and commonest dermatological problem. It is one of the commonest chronic inflammatory diseases of the pilosebaceous unit with multiple pathophysiology which is excessive sebum production, Hyper keratanization, Microbial Colonization especially with Propionibacterium acnes and inflammation. Acne vulgaris clinically manifests as comedones [open(black heads) and closed(white heads)], papules, pustules, nodules, cysts and heals with scars. Acne most commonly develops on face (99%), back (60%) and chest (15%). It is most severe in late teenage years. Acne vulgaris is a pleomorphic disorder it can occurs at any time in life, most commonly it present between 12-24 years of age group and affects approximately 85% of adolescence.
In modern system of medicine many topical drugs like, Adapalene, Retinoic acid, Clindamycin, Benzoyl peroxide etc are used in the treatment of acne vulgaris and many systemic drugs are also given to treat this ailment. Such as; Doxycycline, Erythromycin, Tetracycline and Oxytetracycline, but these drugs have reported many adverse effects like itching, stinging, burning, erythema, dryness, scaling, and redness even contraceptive failure.
In unani medicine, acne vulgaris is treated with hijama-bil-shart (wet cupping), Irsal-e alaq (leech therapy), zimad (paste), tila (liniment), Marham (ointment)etc. to evaluate the effectiveness of these treatment, A clinical study on the effect of Zimad in managing acne vulgaris is proposed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 15.00 Year(s) 至 30.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients of both genders.
- •Patients who are between 15 years to 30 years.
- •Patients willing to follow protocol.
排除标准
- •Patients who are under 15 years and above 30 years.
- •Known case of Diabetes Mellitus.
- •Patients on corticosteroid therapy, anti-convulsant therapy.
- •Known case of any systemic disease or concomitant disorders like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema etc.
- •Patient who do not agree to follow the study protocol.
- •Allergic patient.
结局指标
主要结局
1.Severity of acne
时间窗: 0,7,14,21,28,35 days
2.Cook’s grading scale.
时间窗: 0,7,14,21,28,35 days
次要结局
- 1. Cook’s grading scale.(2. Dermatology life quality index (DLQI).)
研究者
Ariba Javed
State Unani Medical College and hospital himmatganj Prayagraj, UP
